Impact Factor: The Holy Grail of Research

R. Robert,S. Gnanavel
DOI: https://doi.org/10.4103/0253-7176.155678
2015-04-01
Indian Journal of Psychological Medicine
Abstract:10.4103/0253-7176.155663 also found in patients on other antipsychotics like haloperidol or antidepressants such as sertraline and amitryptiline. Various studies have also shown the high prevalence of hypokalemia in psychiatric inpatient settings.[3] Some studies have even shown the prevalence of hypokalemia in psychiatric inpatients to be comparable to medical inpatient settings. The mechanism that was implicated was the antipsychotic usage and the presence of agitation in psychiatric patients. It was postulated that antipsychotics were found to block the potassium efflux channel and prohibit intracellular potassium from shifting into the extracellular compartment leading to hypokalemia, a phenomena that is rarely seen with clinical use of the drugs without any overdose. Agitation can stimulate an adrenergic surge, causing influx of serum potassium into cells, via the overstimulation of beta adrenergic receptors, leading to hypokalemia. Studies have also recognized decreased dietary intake of potassium to be a relatively infrequent cause of hypokalemia significant only when the daily potassium intake is less than one gram (25 mmol)[4] which usually is associated with other features of malnutrition like decreased skin fold thickness, BMI, and serum albumin levels.
What problem does this paper attempt to address?